nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—HTR7—enteric nervous system—Crohn's disease	0.0539	0.172	CbGeAlD
Maprotiline—HTR7—myenteric nerve plexus—Crohn's disease	0.0409	0.13	CbGeAlD
Maprotiline—ORM1—bile—Crohn's disease	0.0392	0.125	CbGeAlD
Maprotiline—CHRM3—muscle of abdomen—Crohn's disease	0.0359	0.114	CbGeAlD
Maprotiline—HTR2A—enteric nervous system—Crohn's disease	0.0336	0.107	CbGeAlD
Maprotiline—HTR2A—myenteric nerve plexus—Crohn's disease	0.0255	0.0811	CbGeAlD
Maprotiline—Drug fever—Mercaptopurine—Crohn's disease	0.0215	0.0465	CcSEcCtD
Maprotiline—Alveolitis allergic—Mesalazine—Crohn's disease	0.0149	0.0323	CcSEcCtD
Maprotiline—Micturition disorder—Mesalazine—Crohn's disease	0.0117	0.0252	CcSEcCtD
Maprotiline—Drug fever—Mesalazine—Crohn's disease	0.0117	0.0252	CcSEcCtD
Maprotiline—ORM1—gall bladder—Crohn's disease	0.0109	0.0346	CbGeAlD
Maprotiline—Bone marrow depression—Mercaptopurine—Crohn's disease	0.0106	0.023	CcSEcCtD
Maprotiline—Electroencephalogram abnormal—Prednisone—Crohn's disease	0.0103	0.0222	CcSEcCtD
Maprotiline—Sinus tachycardia—Mesalazine—Crohn's disease	0.00966	0.0209	CcSEcCtD
Maprotiline—Interstitial pneumonia—Azathioprine—Crohn's disease	0.00884	0.0191	CcSEcCtD
Maprotiline—Interstitial pneumonia—Mesalazine—Crohn's disease	0.00805	0.0174	CcSEcCtD
Maprotiline—Tongue discolouration—Mesalazine—Crohn's disease	0.00805	0.0174	CcSEcCtD
Maprotiline—CHRM5—epithelium—Crohn's disease	0.00764	0.0243	CbGeAlD
Maprotiline—CHRM5—skin of body—Crohn's disease	0.00727	0.0231	CbGeAlD
Maprotiline—HTR7—mouth—Crohn's disease	0.00699	0.0223	CbGeAlD
Maprotiline—Bone marrow depression—Azathioprine—Crohn's disease	0.00633	0.0137	CcSEcCtD
Maprotiline—Interstitial lung disease—Azathioprine—Crohn's disease	0.00603	0.0131	CcSEcCtD
Maprotiline—Abdominal cramps—Mesalazine—Crohn's disease	0.00576	0.0125	CcSEcCtD
Maprotiline—Bone marrow depression—Mesalazine—Crohn's disease	0.00576	0.0125	CcSEcCtD
Maprotiline—Interstitial lung disease—Mesalazine—Crohn's disease	0.0055	0.0119	CcSEcCtD
Maprotiline—Dermatitis atopic—Mesalazine—Crohn's disease	0.00526	0.0114	CcSEcCtD
Maprotiline—Withdrawal symptom—Prednisone—Crohn's disease	0.00502	0.0109	CcSEcCtD
Maprotiline—Breast disorder—Mercaptopurine—Crohn's disease	0.0047	0.0102	CcSEcCtD
Maprotiline—Delirium—Mesalazine—Crohn's disease	0.00452	0.0098	CcSEcCtD
Maprotiline—Bone disorder—Mesalazine—Crohn's disease	0.00431	0.00933	CcSEcCtD
Maprotiline—Pancytopenia—Mercaptopurine—Crohn's disease	0.00427	0.00925	CcSEcCtD
Maprotiline—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.0042	0.00909	CcSEcCtD
Maprotiline—CHRM3—smooth muscle tissue—Crohn's disease	0.00412	0.0131	CbGeAlD
Maprotiline—HTR7—epithelium—Crohn's disease	0.00407	0.0129	CbGeAlD
Maprotiline—HTR7—smooth muscle tissue—Crohn's disease	0.00392	0.0125	CbGeAlD
Maprotiline—Stomatitis—Mercaptopurine—Crohn's disease	0.00391	0.00847	CcSEcCtD
Maprotiline—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00379	0.00822	CcSEcCtD
Maprotiline—CHRM3—digestive system—Crohn's disease	0.00325	0.0103	CbGeAlD
Maprotiline—Alopecia—Mercaptopurine—Crohn's disease	0.00318	0.00689	CcSEcCtD
Maprotiline—Disorientation—Mesalazine—Crohn's disease	0.00316	0.00684	CcSEcCtD
Maprotiline—Malnutrition—Mercaptopurine—Crohn's disease	0.00313	0.00679	CcSEcCtD
Maprotiline—HTR7—digestive system—Crohn's disease	0.00309	0.00985	CbGeAlD
Maprotiline—Libido decreased—Mesalazine—Crohn's disease	0.00305	0.0066	CcSEcCtD
Maprotiline—HRH1—epithelium—Crohn's disease	0.00304	0.00967	CbGeAlD
Maprotiline—Increased appetite—Mesalazine—Crohn's disease	0.00301	0.00651	CcSEcCtD
Maprotiline—HRH1—smooth muscle tissue—Crohn's disease	0.00293	0.00931	CbGeAlD
Maprotiline—Delusion—Prednisone—Crohn's disease	0.00291	0.0063	CcSEcCtD
Maprotiline—Desipramine—SLC22A4—Crohn's disease	0.00284	0.35	CrCbGaD
Maprotiline—Mania—Prednisone—Crohn's disease	0.00283	0.00613	CcSEcCtD
Maprotiline—Osteoarthritis—Mesalazine—Crohn's disease	0.00282	0.00612	CcSEcCtD
Maprotiline—Leukopenia—Mercaptopurine—Crohn's disease	0.0028	0.00608	CcSEcCtD
Maprotiline—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.0028	0.00607	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00279	0.00605	CcSEcCtD
Maprotiline—Dermatitis atopic—Prednisone—Crohn's disease	0.00278	0.00602	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00265	0.00574	CcSEcCtD
Maprotiline—HRH1—mammalian vulva—Crohn's disease	0.00263	0.00838	CbGeAlD
Maprotiline—Memory impairment—Prednisone—Crohn's disease	0.00262	0.00568	CcSEcCtD
Maprotiline—Liver function test abnormal—Mesalazine—Crohn's disease	0.00261	0.00565	CcSEcCtD
Maprotiline—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00258	0.00559	CcSEcCtD
Maprotiline—Oedema—Mercaptopurine—Crohn's disease	0.00256	0.00554	CcSEcCtD
Maprotiline—Breast disorder—Mesalazine—Crohn's disease	0.00255	0.00553	CcSEcCtD
Maprotiline—Pancytopenia—Azathioprine—Crohn's disease	0.00254	0.00551	CcSEcCtD
Maprotiline—HTR2A—epithelium—Crohn's disease	0.00254	0.00807	CbGeAlD
Maprotiline—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.0025	0.00542	CcSEcCtD
Maprotiline—Petechiae—Prednisone—Crohn's disease	0.0025	0.00542	CcSEcCtD
Maprotiline—Skin disorder—Mercaptopurine—Crohn's disease	0.00248	0.00538	CcSEcCtD
Maprotiline—Endocrine disorder—Prednisone—Crohn's disease	0.00248	0.00538	CcSEcCtD
Maprotiline—CYP1A2—digestive system—Crohn's disease	0.00247	0.00786	CbGeAlD
Maprotiline—ORM1—lymph node—Crohn's disease	0.00244	0.00778	CbGeAlD
Maprotiline—HTR2A—smooth muscle tissue—Crohn's disease	0.00244	0.00778	CbGeAlD
Maprotiline—Dysphagia—Mesalazine—Crohn's disease	0.00244	0.00529	CcSEcCtD
Maprotiline—Eosinophilia—Mesalazine—Crohn's disease	0.00242	0.00524	CcSEcCtD
Maprotiline—Imipramine—SLC22A4—Crohn's disease	0.00241	0.297	CrCbGaD
Maprotiline—Bronchospasm—Mesalazine—Crohn's disease	0.0024	0.0052	CcSEcCtD
Maprotiline—Delirium—Prednisone—Crohn's disease	0.00239	0.00518	CcSEcCtD
Maprotiline—Infestation—Azathioprine—Crohn's disease	0.00239	0.00518	CcSEcCtD
Maprotiline—Infestation NOS—Azathioprine—Crohn's disease	0.00239	0.00518	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00237	0.00513	CcSEcCtD
Maprotiline—Pancytopenia—Mesalazine—Crohn's disease	0.00232	0.00502	CcSEcCtD
Maprotiline—HRH1—digestive system—Crohn's disease	0.00231	0.00735	CbGeAlD
Maprotiline—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00226	0.00489	CcSEcCtD
Maprotiline—Pollakiuria—Mesalazine—Crohn's disease	0.00225	0.00488	CcSEcCtD
Maprotiline—Agranulocytosis—Azathioprine—Crohn's disease	0.00223	0.00483	CcSEcCtD
Maprotiline—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00223	0.00483	CcSEcCtD
Maprotiline—Weight increased—Mesalazine—Crohn's disease	0.00222	0.00481	CcSEcCtD
Maprotiline—Weight decreased—Mesalazine—Crohn's disease	0.00221	0.00478	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00221	0.00478	CcSEcCtD
Maprotiline—Infestation—Mesalazine—Crohn's disease	0.00218	0.00471	CcSEcCtD
Maprotiline—Infestation NOS—Mesalazine—Crohn's disease	0.00218	0.00471	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00216	0.00467	CcSEcCtD
Maprotiline—Desipramine—SLC22A5—Crohn's disease	0.00213	0.263	CrCbGaD
Maprotiline—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00213	0.00462	CcSEcCtD
Maprotiline—Stomatitis—Mesalazine—Crohn's disease	0.00212	0.0046	CcSEcCtD
Maprotiline—Jaundice—Mesalazine—Crohn's disease	0.00212	0.0046	CcSEcCtD
Maprotiline—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00206	0.00446	CcSEcCtD
Maprotiline—Agranulocytosis—Mesalazine—Crohn's disease	0.00203	0.0044	CcSEcCtD
Maprotiline—Erythema multiforme—Azathioprine—Crohn's disease	0.00203	0.00439	CcSEcCtD
Maprotiline—Body temperature increased—Mercaptopurine—Crohn's disease	0.00202	0.00438	CcSEcCtD
Maprotiline—Hepatitis—Mesalazine—Crohn's disease	0.00195	0.00423	CcSEcCtD
Maprotiline—Mediastinal disorder—Azathioprine—Crohn's disease	0.00193	0.00419	CcSEcCtD
Maprotiline—HTR2A—digestive system—Crohn's disease	0.00193	0.00614	CbGeAlD
Maprotiline—Urinary tract disorder—Mesalazine—Crohn's disease	0.00193	0.00418	CcSEcCtD
Maprotiline—Arrhythmia—Azathioprine—Crohn's disease	0.00192	0.00415	CcSEcCtD
Maprotiline—Urethral disorder—Mesalazine—Crohn's disease	0.00191	0.00415	CcSEcCtD
Maprotiline—Alopecia—Azathioprine—Crohn's disease	0.0019	0.00411	CcSEcCtD
Maprotiline—Erythema multiforme—Mesalazine—Crohn's disease	0.00185	0.004	CcSEcCtD
Maprotiline—SLC6A2—lymph node—Crohn's disease	0.00183	0.00584	CbGeAlD
Maprotiline—Eye disorder—Mesalazine—Crohn's disease	0.00183	0.00396	CcSEcCtD
Maprotiline—Tinnitus—Mesalazine—Crohn's disease	0.00182	0.00395	CcSEcCtD
Maprotiline—Cardiac disorder—Mesalazine—Crohn's disease	0.00181	0.00393	CcSEcCtD
Maprotiline—Hyperkinesia—Prednisone—Crohn's disease	0.0018	0.00389	CcSEcCtD
Maprotiline—Angiopathy—Mesalazine—Crohn's disease	0.00177	0.00384	CcSEcCtD
Maprotiline—Mediastinal disorder—Mesalazine—Crohn's disease	0.00176	0.00381	CcSEcCtD
Maprotiline—CYP2D6—digestive system—Crohn's disease	0.00176	0.0056	CbGeAlD
Maprotiline—Diarrhoea—Mercaptopurine—Crohn's disease	0.00175	0.00379	CcSEcCtD
Maprotiline—Alopecia—Mesalazine—Crohn's disease	0.00173	0.00374	CcSEcCtD
Maprotiline—Leukopenia—Azathioprine—Crohn's disease	0.00167	0.00362	CcSEcCtD
Maprotiline—Vascular purpura—Prednisone—Crohn's disease	0.00167	0.00362	CcSEcCtD
Maprotiline—Tension—Mesalazine—Crohn's disease	0.00167	0.00362	CcSEcCtD
Maprotiline—Dysgeusia—Mesalazine—Crohn's disease	0.00167	0.00361	CcSEcCtD
Maprotiline—ABCB1—epithelium—Crohn's disease	0.00166	0.00529	CbGeAlD
Maprotiline—Nervousness—Mesalazine—Crohn's disease	0.00165	0.00358	CcSEcCtD
Maprotiline—Vomiting—Mercaptopurine—Crohn's disease	0.00163	0.00352	CcSEcCtD
Maprotiline—Rash—Mercaptopurine—Crohn's disease	0.00161	0.00349	CcSEcCtD
Maprotiline—Dermatitis—Mercaptopurine—Crohn's disease	0.00161	0.00349	CcSEcCtD
Maprotiline—Vision blurred—Mesalazine—Crohn's disease	0.0016	0.00347	CcSEcCtD
Maprotiline—Tremor—Mesalazine—Crohn's disease	0.00159	0.00345	CcSEcCtD
Maprotiline—Increased appetite—Prednisone—Crohn's disease	0.00159	0.00345	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00158	0.00342	CcSEcCtD
Maprotiline—Purpura—Prednisone—Crohn's disease	0.00155	0.00336	CcSEcCtD
Maprotiline—Syncope—Mesalazine—Crohn's disease	0.00153	0.0033	CcSEcCtD
Maprotiline—Leukopenia—Mesalazine—Crohn's disease	0.00152	0.0033	CcSEcCtD
Maprotiline—Nausea—Mercaptopurine—Crohn's disease	0.00152	0.00329	CcSEcCtD
Maprotiline—Infection—Azathioprine—Crohn's disease	0.00151	0.00328	CcSEcCtD
Maprotiline—Palpitations—Mesalazine—Crohn's disease	0.0015	0.00326	CcSEcCtD
Maprotiline—Loss of consciousness—Mesalazine—Crohn's disease	0.00149	0.00324	CcSEcCtD
Maprotiline—Osteoarthritis—Prednisone—Crohn's disease	0.00149	0.00324	CcSEcCtD
Maprotiline—Thrombocytopenia—Azathioprine—Crohn's disease	0.00149	0.00323	CcSEcCtD
Maprotiline—Skin disorder—Azathioprine—Crohn's disease	0.00148	0.00321	CcSEcCtD
Maprotiline—Hypertension—Mesalazine—Crohn's disease	0.00147	0.00318	CcSEcCtD
Maprotiline—Psychotic disorder—Prednisone—Crohn's disease	0.00146	0.00316	CcSEcCtD
Maprotiline—Anxiety—Mesalazine—Crohn's disease	0.00144	0.00313	CcSEcCtD
Maprotiline—ABCB1—mammalian vulva—Crohn's disease	0.00144	0.00459	CbGeAlD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00144	0.00311	CcSEcCtD
Maprotiline—Hypotension—Azathioprine—Crohn's disease	0.00142	0.00308	CcSEcCtD
Maprotiline—Dry mouth—Mesalazine—Crohn's disease	0.00142	0.00307	CcSEcCtD
Maprotiline—Confusional state—Mesalazine—Crohn's disease	0.0014	0.00303	CcSEcCtD
Maprotiline—Oedema—Mesalazine—Crohn's disease	0.00139	0.00301	CcSEcCtD
Maprotiline—Infection—Mesalazine—Crohn's disease	0.00138	0.00299	CcSEcCtD
Maprotiline—Shock—Mesalazine—Crohn's disease	0.00137	0.00296	CcSEcCtD
Maprotiline—Nervous system disorder—Mesalazine—Crohn's disease	0.00136	0.00295	CcSEcCtD
Maprotiline—Thrombocytopenia—Mesalazine—Crohn's disease	0.00136	0.00294	CcSEcCtD
Maprotiline—Tachycardia—Mesalazine—Crohn's disease	0.00135	0.00293	CcSEcCtD
Maprotiline—Skin disorder—Mesalazine—Crohn's disease	0.00135	0.00292	CcSEcCtD
Maprotiline—Hyperhidrosis—Mesalazine—Crohn's disease	0.00134	0.00291	CcSEcCtD
Maprotiline—HRH1—lymph node—Crohn's disease	0.00132	0.0042	CbGeAlD
Maprotiline—Muscular weakness—Prednisone—Crohn's disease	0.00132	0.00285	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00132	0.00285	CcSEcCtD
Maprotiline—Hypotension—Mesalazine—Crohn's disease	0.0013	0.00281	CcSEcCtD
Maprotiline—ABCB1—lymphoid tissue—Crohn's disease	0.00128	0.00407	CbGeAlD
Maprotiline—ABCB1—digestive system—Crohn's disease	0.00126	0.00402	CbGeAlD
Maprotiline—Sweating increased—Prednisone—Crohn's disease	0.00126	0.00273	CcSEcCtD
Maprotiline—Feeling abnormal—Azathioprine—Crohn's disease	0.00126	0.00272	CcSEcCtD
Maprotiline—Insomnia—Mesalazine—Crohn's disease	0.00126	0.00272	CcSEcCtD
Maprotiline—Paraesthesia—Mesalazine—Crohn's disease	0.00125	0.0027	CcSEcCtD
Maprotiline—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00125	0.0027	CcSEcCtD
Maprotiline—Somnolence—Mesalazine—Crohn's disease	0.00123	0.00267	CcSEcCtD
Maprotiline—Dyspepsia—Mesalazine—Crohn's disease	0.00122	0.00265	CcSEcCtD
Maprotiline—Abdominal pain—Azathioprine—Crohn's disease	0.0012	0.00261	CcSEcCtD
Maprotiline—Body temperature increased—Azathioprine—Crohn's disease	0.0012	0.00261	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.0012	0.0026	CcSEcCtD
Maprotiline—Fatigue—Mesalazine—Crohn's disease	0.0012	0.00259	CcSEcCtD
Maprotiline—Erectile dysfunction—Prednisone—Crohn's disease	0.00119	0.00258	CcSEcCtD
Maprotiline—Constipation—Mesalazine—Crohn's disease	0.00119	0.00257	CcSEcCtD
Maprotiline—Weight increased—Prednisone—Crohn's disease	0.00118	0.00255	CcSEcCtD
Maprotiline—Weight decreased—Prednisone—Crohn's disease	0.00117	0.00253	CcSEcCtD
Maprotiline—Feeling abnormal—Mesalazine—Crohn's disease	0.00114	0.00248	CcSEcCtD
Maprotiline—Acute coronary syndrome—Prednisone—Crohn's disease	0.00113	0.00246	CcSEcCtD
Maprotiline—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00113	0.00246	CcSEcCtD
Maprotiline—Myocardial infarction—Prednisone—Crohn's disease	0.00113	0.00244	CcSEcCtD
Maprotiline—Neuropathy peripheral—Prednisone—Crohn's disease	0.00113	0.00244	CcSEcCtD
Maprotiline—Urticaria—Mesalazine—Crohn's disease	0.0011	0.00239	CcSEcCtD
Maprotiline—Abdominal pain—Mesalazine—Crohn's disease	0.0011	0.00238	CcSEcCtD
Maprotiline—Body temperature increased—Mesalazine—Crohn's disease	0.0011	0.00238	CcSEcCtD
Maprotiline—Diarrhoea—Azathioprine—Crohn's disease	0.00104	0.00226	CcSEcCtD
Maprotiline—Hallucination—Prednisone—Crohn's disease	0.00103	0.00223	CcSEcCtD
Maprotiline—Dizziness—Azathioprine—Crohn's disease	0.00101	0.00218	CcSEcCtD
Maprotiline—Asthenia—Mesalazine—Crohn's disease	0.000996	0.00216	CcSEcCtD
Maprotiline—Pruritus—Mesalazine—Crohn's disease	0.000982	0.00213	CcSEcCtD
Maprotiline—Vomiting—Azathioprine—Crohn's disease	0.000969	0.0021	CcSEcCtD
Maprotiline—Eye disorder—Prednisone—Crohn's disease	0.000966	0.00209	CcSEcCtD
Maprotiline—Rash—Azathioprine—Crohn's disease	0.000961	0.00208	CcSEcCtD
Maprotiline—Dermatitis—Azathioprine—Crohn's disease	0.00096	0.00208	CcSEcCtD
Maprotiline—Flushing—Prednisone—Crohn's disease	0.000959	0.00208	CcSEcCtD
Maprotiline—Headache—Azathioprine—Crohn's disease	0.000955	0.00207	CcSEcCtD
Maprotiline—Diarrhoea—Mesalazine—Crohn's disease	0.00095	0.00206	CcSEcCtD
Maprotiline—Angiopathy—Prednisone—Crohn's disease	0.000938	0.00203	CcSEcCtD
Maprotiline—Arrhythmia—Prednisone—Crohn's disease	0.000923	0.002	CcSEcCtD
Maprotiline—Dizziness—Mesalazine—Crohn's disease	0.000918	0.00199	CcSEcCtD
Maprotiline—Alopecia—Prednisone—Crohn's disease	0.000913	0.00198	CcSEcCtD
Maprotiline—Nausea—Azathioprine—Crohn's disease	0.000905	0.00196	CcSEcCtD
Maprotiline—Malnutrition—Prednisone—Crohn's disease	0.0009	0.00195	CcSEcCtD
Maprotiline—Vomiting—Mesalazine—Crohn's disease	0.000882	0.00191	CcSEcCtD
Maprotiline—Rash—Mesalazine—Crohn's disease	0.000875	0.0019	CcSEcCtD
Maprotiline—Dermatitis—Mesalazine—Crohn's disease	0.000874	0.00189	CcSEcCtD
Maprotiline—Headache—Mesalazine—Crohn's disease	0.000869	0.00188	CcSEcCtD
Maprotiline—Vision blurred—Prednisone—Crohn's disease	0.000848	0.00184	CcSEcCtD
Maprotiline—Agitation—Prednisone—Crohn's disease	0.000827	0.00179	CcSEcCtD
Maprotiline—Nausea—Mesalazine—Crohn's disease	0.000824	0.00179	CcSEcCtD
Maprotiline—Syncope—Prednisone—Crohn's disease	0.000807	0.00175	CcSEcCtD
Maprotiline—Loss of consciousness—Prednisone—Crohn's disease	0.000791	0.00171	CcSEcCtD
Maprotiline—Convulsion—Prednisone—Crohn's disease	0.00078	0.00169	CcSEcCtD
Maprotiline—Hypertension—Prednisone—Crohn's disease	0.000777	0.00168	CcSEcCtD
Maprotiline—Anxiety—Prednisone—Crohn's disease	0.000763	0.00165	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000761	0.00165	CcSEcCtD
Maprotiline—Oedema—Prednisone—Crohn's disease	0.000734	0.00159	CcSEcCtD
Maprotiline—Infection—Prednisone—Crohn's disease	0.00073	0.00158	CcSEcCtD
Maprotiline—Shock—Prednisone—Crohn's disease	0.000722	0.00157	CcSEcCtD
Maprotiline—ABCB1—lymph node—Crohn's disease	0.000722	0.0023	CbGeAlD
Maprotiline—Nervous system disorder—Prednisone—Crohn's disease	0.00072	0.00156	CcSEcCtD
Maprotiline—Nortriptyline—ALB—Crohn's disease	0.000719	0.0887	CrCbGaD
Maprotiline—Tachycardia—Prednisone—Crohn's disease	0.000717	0.00155	CcSEcCtD
Maprotiline—Skin disorder—Prednisone—Crohn's disease	0.000713	0.00155	CcSEcCtD
Maprotiline—Hyperhidrosis—Prednisone—Crohn's disease	0.00071	0.00154	CcSEcCtD
Maprotiline—Insomnia—Prednisone—Crohn's disease	0.000664	0.00144	CcSEcCtD
Maprotiline—Paraesthesia—Prednisone—Crohn's disease	0.000659	0.00143	CcSEcCtD
Maprotiline—Dyspepsia—Prednisone—Crohn's disease	0.000646	0.0014	CcSEcCtD
Maprotiline—Fatigue—Prednisone—Crohn's disease	0.000633	0.00137	CcSEcCtD
Maprotiline—Constipation—Prednisone—Crohn's disease	0.000628	0.00136	CcSEcCtD
Maprotiline—Feeling abnormal—Prednisone—Crohn's disease	0.000605	0.00131	CcSEcCtD
Maprotiline—Gastrointestinal pain—Prednisone—Crohn's disease	0.0006	0.0013	CcSEcCtD
Maprotiline—Urticaria—Prednisone—Crohn's disease	0.000583	0.00126	CcSEcCtD
Maprotiline—Abdominal pain—Prednisone—Crohn's disease	0.00058	0.00126	CcSEcCtD
Maprotiline—Body temperature increased—Prednisone—Crohn's disease	0.00058	0.00126	CcSEcCtD
Maprotiline—Asthenia—Prednisone—Crohn's disease	0.000527	0.00114	CcSEcCtD
Maprotiline—Pruritus—Prednisone—Crohn's disease	0.00052	0.00113	CcSEcCtD
Maprotiline—Diarrhoea—Prednisone—Crohn's disease	0.000502	0.00109	CcSEcCtD
Maprotiline—Dizziness—Prednisone—Crohn's disease	0.000486	0.00105	CcSEcCtD
Maprotiline—Vomiting—Prednisone—Crohn's disease	0.000467	0.00101	CcSEcCtD
Maprotiline—Rash—Prednisone—Crohn's disease	0.000463	0.001	CcSEcCtD
Maprotiline—Dermatitis—Prednisone—Crohn's disease	0.000463	0.001	CcSEcCtD
Maprotiline—Headache—Prednisone—Crohn's disease	0.00046	0.000997	CcSEcCtD
Maprotiline—Nausea—Prednisone—Crohn's disease	0.000436	0.000945	CcSEcCtD
Maprotiline—HTR7—Signaling Pathways—RIPK2—Crohn's disease	7.93e-05	0.000367	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MTMR3—Crohn's disease	7.93e-05	0.000367	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	7.9e-05	0.000365	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL3—Crohn's disease	7.73e-05	0.000358	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—UBE2D1—Crohn's disease	7.72e-05	0.000357	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCR6—Crohn's disease	7.6e-05	0.000352	CbGpPWpGaD
Maprotiline—DRD2—Circadian rythm related genes—IL6—Crohn's disease	7.5e-05	0.000347	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—RIPK2—Crohn's disease	7.49e-05	0.000346	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—RASGRP1—Crohn's disease	7.48e-05	0.000346	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—IL2RA—Crohn's disease	7.44e-05	0.000344	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—UBE2D1—Crohn's disease	7.4e-05	0.000342	CbGpPWpGaD
Maprotiline—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	7.34e-05	0.000339	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL3—Crohn's disease	7.3e-05	0.000338	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—RIPK2—Crohn's disease	7.17e-05	0.000332	CbGpPWpGaD
Maprotiline—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	7.13e-05	0.00033	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—RASGRP1—Crohn's disease	7.06e-05	0.000327	CbGpPWpGaD
Maprotiline—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	7.02e-05	0.000325	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	7e-05	0.000324	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL3—Crohn's disease	6.99e-05	0.000324	CbGpPWpGaD
Maprotiline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	6.99e-05	0.000323	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	6.98e-05	0.000323	CbGpPWpGaD
Maprotiline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	6.98e-05	0.000323	CbGpPWpGaD
Maprotiline—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	6.96e-05	0.000322	CbGpPWpGaD
Maprotiline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	6.95e-05	0.000322	CbGpPWpGaD
Maprotiline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	6.93e-05	0.000321	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	6.89e-05	0.000319	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—RBX1—Crohn's disease	6.88e-05	0.000318	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—JAK2—Crohn's disease	6.79e-05	0.000314	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—SOCS1—Crohn's disease	6.78e-05	0.000313	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—RASGRP1—Crohn's disease	6.76e-05	0.000313	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL2RA—Crohn's disease	6.76e-05	0.000313	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MTMR3—Crohn's disease	6.72e-05	0.000311	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCR6—Crohn's disease	6.71e-05	0.00031	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PTGER4—Crohn's disease	6.69e-05	0.00031	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCR6—Crohn's disease	6.6e-05	0.000305	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCR6—Crohn's disease	6.59e-05	0.000305	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	6.57e-05	0.000304	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCR6—Crohn's disease	6.57e-05	0.000304	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—FADS1—Crohn's disease	6.55e-05	0.000303	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCR6—Crohn's disease	6.55e-05	0.000303	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCR6—Crohn's disease	6.48e-05	0.0003	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	6.46e-05	0.000299	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—TYK2—Crohn's disease	6.46e-05	0.000299	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	6.45e-05	0.000298	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	6.43e-05	0.000297	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—JAK2—Crohn's disease	6.41e-05	0.000297	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	6.41e-05	0.000297	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—SOCS1—Crohn's disease	6.4e-05	0.000296	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	6.35e-05	0.000294	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—CXCL8—Crohn's disease	6.19e-05	0.000287	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—FADS1—Crohn's disease	6.18e-05	0.000286	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—JAK2—Crohn's disease	6.16e-05	0.000285	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—JAK2—Crohn's disease	6.14e-05	0.000284	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GPX4—Crohn's disease	6.14e-05	0.000284	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SOCS1—Crohn's disease	6.13e-05	0.000284	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—TYK2—Crohn's disease	6.1e-05	0.000282	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—RBX1—Crohn's disease	6.07e-05	0.000281	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—UBE2D1—Crohn's disease	6.03e-05	0.000279	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	5.99e-05	0.000277	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—RBX1—Crohn's disease	5.97e-05	0.000276	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	5.97e-05	0.000276	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—RBX1—Crohn's disease	5.96e-05	0.000276	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—RBX1—Crohn's disease	5.94e-05	0.000275	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GCKR—Crohn's disease	5.93e-05	0.000274	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—RBX1—Crohn's disease	5.92e-05	0.000274	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PTGER4—Crohn's disease	5.91e-05	0.000273	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	5.87e-05	0.000272	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—RBX1—Crohn's disease	5.86e-05	0.000271	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	5.86e-05	0.000271	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—SMAD3—Crohn's disease	5.85e-05	0.000271	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—CXCL8—Crohn's disease	5.85e-05	0.000271	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	5.85e-05	0.00027	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—TYK2—Crohn's disease	5.84e-05	0.00027	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	5.84e-05	0.00027	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—JAK2—Crohn's disease	5.82e-05	0.000269	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	5.82e-05	0.000269	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	5.81e-05	0.000269	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PTGER4—Crohn's disease	5.8e-05	0.000268	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GPX4—Crohn's disease	5.78e-05	0.000268	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	5.78e-05	0.000267	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	5.76e-05	0.000267	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	5.76e-05	0.000267	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	5.71e-05	0.000264	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL3—Crohn's disease	5.7e-05	0.000264	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—CXCL8—Crohn's disease	5.63e-05	0.00026	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—CXCL8—Crohn's disease	5.6e-05	0.000259	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GCKR—Crohn's disease	5.59e-05	0.000258	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—JAK2—Crohn's disease	5.57e-05	0.000258	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—SMAD3—Crohn's disease	5.52e-05	0.000256	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	5.51e-05	0.000255	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL2RA—Crohn's disease	5.42e-05	0.000251	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	5.32e-05	0.000246	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—CXCL8—Crohn's disease	5.31e-05	0.000246	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	5.29e-05	0.000245	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	5.24e-05	0.000242	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—FADS1—Crohn's disease	5.23e-05	0.000242	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	5.22e-05	0.000242	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	5.21e-05	0.000241	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	5.19e-05	0.00024	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—RIPK2—Crohn's disease	5.16e-05	0.000239	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	5.14e-05	0.000238	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL2RA—Crohn's disease	5.12e-05	0.000237	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	5.09e-05	0.000235	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	5.08e-05	0.000235	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—RIPK2—Crohn's disease	5.07e-05	0.000234	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	5.05e-05	0.000234	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	5.03e-05	0.000233	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL3—Crohn's disease	5.03e-05	0.000233	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	5e-05	0.000231	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	5e-05	0.000231	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	4.98e-05	0.000231	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL3—Crohn's disease	4.95e-05	0.000229	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL3—Crohn's disease	4.94e-05	0.000229	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL3—Crohn's disease	4.92e-05	0.000228	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL3—Crohn's disease	4.91e-05	0.000227	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GPX4—Crohn's disease	4.9e-05	0.000227	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	4.9e-05	0.000227	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	4.87e-05	0.000225	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL3—Crohn's disease	4.86e-05	0.000225	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	4.79e-05	0.000222	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	4.78e-05	0.000221	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	4.76e-05	0.00022	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	4.76e-05	0.00022	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	4.75e-05	0.00022	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GCKR—Crohn's disease	4.73e-05	0.000219	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	4.7e-05	0.000218	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	4.57e-05	0.000211	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	4.54e-05	0.00021	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	4.42e-05	0.000204	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SOCS1—Crohn's disease	4.41e-05	0.000204	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	4.35e-05	0.000201	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	4.34e-05	0.000201	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	4.34e-05	0.000201	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SOCS1—Crohn's disease	4.33e-05	0.0002	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	4.32e-05	0.0002	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	4.31e-05	0.0002	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	4.31e-05	0.0002	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	4.31e-05	0.000199	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	4.3e-05	0.000199	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	4.27e-05	0.000197	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	4.26e-05	0.000197	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—TYK2—Crohn's disease	4.2e-05	0.000194	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	4.15e-05	0.000192	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	4.14e-05	0.000191	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—TYK2—Crohn's disease	4.13e-05	0.000191	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	4.11e-05	0.00019	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	4.1e-05	0.00019	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	4.06e-05	0.000188	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	4.03e-05	0.000186	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.03e-05	0.000186	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—JAK2—Crohn's disease	4.01e-05	0.000186	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	3.99e-05	0.000185	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	3.97e-05	0.000183	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	3.96e-05	0.000183	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	3.95e-05	0.000183	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	3.94e-05	0.000182	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—JAK2—Crohn's disease	3.94e-05	0.000182	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	3.93e-05	0.000182	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	3.92e-05	0.000182	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	3.91e-05	0.000181	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	3.89e-05	0.00018	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	3.87e-05	0.000179	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TYK2—Crohn's disease	3.82e-05	0.000177	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SMAD3—Crohn's disease	3.81e-05	0.000176	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	3.75e-05	0.000173	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SMAD3—Crohn's disease	3.74e-05	0.000173	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	3.73e-05	0.000172	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	3.71e-05	0.000172	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	3.68e-05	0.00017	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	3.66e-05	0.000169	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—JAK2—Crohn's disease	3.64e-05	0.000168	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TYK2—Crohn's disease	3.6e-05	0.000167	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	3.6e-05	0.000167	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	3.59e-05	0.000166	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	3.58e-05	0.000166	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	3.57e-05	0.000165	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	3.54e-05	0.000164	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL2RA—Crohn's disease	3.52e-05	0.000163	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	3.47e-05	0.00016	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL2RA—Crohn's disease	3.46e-05	0.00016	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TYK2—Crohn's disease	3.45e-05	0.00016	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	3.45e-05	0.00016	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—JAK2—Crohn's disease	3.44e-05	0.000159	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	3.44e-05	0.000159	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	3.41e-05	0.000158	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.38e-05	0.000156	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CXCL8—Crohn's disease	3.32e-05	0.000154	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—JAK2—Crohn's disease	3.29e-05	0.000152	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—IL6—Crohn's disease	3.16e-05	0.000146	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	3.14e-05	0.000145	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	3.01e-05	0.000139	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL6—Crohn's disease	2.98e-05	0.000138	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ALB—Crohn's disease	2.97e-05	0.000138	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.96e-05	0.000137	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL6—Crohn's disease	2.86e-05	0.000132	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TYK2—Crohn's disease	2.81e-05	0.00013	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—JAK2—Crohn's disease	2.68e-05	0.000124	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—STAT3—Crohn's disease	2.67e-05	0.000124	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PTGS2—Crohn's disease	2.6e-05	0.00012	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—STAT3—Crohn's disease	2.52e-05	0.000117	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TYK2—Crohn's disease	2.48e-05	0.000115	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	2.45e-05	0.000113	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TYK2—Crohn's disease	2.44e-05	0.000113	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TYK2—Crohn's disease	2.44e-05	0.000113	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TYK2—Crohn's disease	2.43e-05	0.000112	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TYK2—Crohn's disease	2.42e-05	0.000112	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—STAT3—Crohn's disease	2.42e-05	0.000112	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TYK2—Crohn's disease	2.4e-05	0.000111	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—JAK2—Crohn's disease	2.37e-05	0.00011	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—JAK2—Crohn's disease	2.33e-05	0.000108	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—Crohn's disease	2.33e-05	0.000108	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—JAK2—Crohn's disease	2.33e-05	0.000108	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—JAK2—Crohn's disease	2.32e-05	0.000107	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—JAK2—Crohn's disease	2.31e-05	0.000107	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—JAK2—Crohn's disease	2.29e-05	0.000106	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CXCL8—Crohn's disease	2.16e-05	0.0001	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	2.13e-05	9.84e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CXCL8—Crohn's disease	2.12e-05	9.82e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	2.12e-05	9.79e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	2.11e-05	9.76e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	2.09e-05	9.66e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—Crohn's disease	2.06e-05	9.51e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—Crohn's disease	2.02e-05	9.36e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—Crohn's disease	2.02e-05	9.34e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—Crohn's disease	2.01e-05	9.31e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—Crohn's disease	2.01e-05	9.28e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—Crohn's disease	1.99e-05	9.19e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—STAT3—Crohn's disease	1.97e-05	9.11e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ALB—Crohn's disease	1.89e-05	8.73e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—Crohn's disease	1.87e-05	8.64e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ALB—Crohn's disease	1.78e-05	8.22e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—Crohn's disease	1.76e-05	8.16e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—STAT3—Crohn's disease	1.74e-05	8.04e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—STAT3—Crohn's disease	1.71e-05	7.92e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—STAT3—Crohn's disease	1.71e-05	7.9e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—STAT3—Crohn's disease	1.7e-05	7.87e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—STAT3—Crohn's disease	1.7e-05	7.85e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—Crohn's disease	1.69e-05	7.81e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—STAT3—Crohn's disease	1.68e-05	7.77e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTGS2—Crohn's disease	1.65e-05	7.64e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.56e-05	7.19e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALB—Crohn's disease	1.51e-05	6.97e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—Crohn's disease	1.38e-05	6.37e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.32e-05	6.1e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—Crohn's disease	1.21e-05	5.62e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.2e-05	5.53e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—Crohn's disease	1.19e-05	5.52e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—Crohn's disease	1.19e-05	5.5e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—Crohn's disease	1.18e-05	5.48e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—Crohn's disease	1.17e-05	5.43e-05	CbGpPWpGaD
